HSBC Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a €78.00 Price Target

HSBC set a €78.00 ($90.70) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report released on Monday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Other equities analysts also recently issued research reports about the stock. UBS Group set a €90.00 ($104.65) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, October 29th. Nord/LB set a €82.00 ($95.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Wednesday, October 30th. Morgan Stanley set a €58.00 ($67.44) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Thursday, September 12th. Goldman Sachs Group set a €80.00 ($93.02) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, November 5th. Finally, Berenberg Bank set a €89.95 ($104.59) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, October 29th. Eight analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA has an average rating of Buy and a consensus target price of €77.63 ($90.26).

ETR:FME traded up €0.36 ($0.42) on Monday, hitting €67.14 ($78.07). The company had a trading volume of 954,401 shares, compared to its average volume of 704,197. The stock has a market capitalization of $20.26 billion and a price-to-earnings ratio of 15.97. The company has a current ratio of 0.98, a quick ratio of 0.62 and a debt-to-equity ratio of 101.27. The firm has a 50 day moving average of €62.46 and a two-hundred day moving average of €65.40. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €55.44 ($64.47) and a 52 week high of €76.68 ($89.16).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: What are the FAANG Stocks?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit